糖心vlog传媒

logo

Germany Nuclear Imaging Market Size (2024 - 2029)

The Germany nuclear imaging market is experiencing significant growth, driven by factors such as the increasing prevalence of chronic diseases and the strategic presence of key companies in the sector. Despite the challenges posed by the COVID-19 pandemic, which led to the postponement of non-essential diagnostic procedures, the market has seen opportunities for expansion through the introduction of new products and advancements in clinical studies. Partnerships within the industry are further enhancing the market's development, as companies collaborate to offer innovative solutions for theranostic drug development. These dynamics are contributing to the robust growth trajectory of the nuclear imaging market in Germany.

Home Market Analysis Healthcare Research Medical Devices Research Medical Imaging Research Diagnostic Imaging Research Nuclear Medicine Imaging Research Germany Nuclear Imaging Market Market Size

Market Size of Germany Nuclear Imaging Industry

CAGR
Study Period 2019 - 2029
Base Year For Estimation 2023
Market Size (2024) USD 504.08 Million
Market Size (2029) USD 614.17 Million
CAGR (2024 - 2029) 4.03 %
Market Concentration Medium

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order

Germany Nuclear Imaging Market Analysis

The Germany Nuclear Imaging Market size is estimated at USD 504.08 million in 2024, and is expected to reach USD 614.17 million by 2029, growing at a CAGR of 4.03% during the forecast period (2024-2029).

COVID-19 has severely impacted the market studied during the year 2020 owing to quick actions taken by the government for postponing non-essential diagnostic procedures in hospitals. Besides the negative impact of COVID-19, it has created opportunities for players in the nuclear imaging field to establish their presence by launching new products or progressing clinical studies in this field. For instance, in April 2021, Isotopen Technologien Munchen, Germany received a USD 109 million loan to push forward the study of Lutetium-177 which is expected to emit a low amount of radioactive energy as compared to other radiopharmaceuticals. Owing to such activities in the country, the nuclear imaging market is getting the benefits and is expected to witness strong growth in the coming years.

Factors such as the increasing burden of chronic diseases and the presence of key companies in the country are responsible for the market growth. Furthermore, many companies entered into a partnership to provide the radiopharmaceutical industry with a unique service solution for theranostic drug development. For instance, in July 2021, Oncodesign, Covalab, CheMatech, and ABX-CRO entered into a partnership to launch DRIVE-MRT (Molecular Radiotherapy) solution, which will have all technologies related to the validation of targets, the generation and optimization of vectors and the radiochemistry and PET / SPECT imaging techniques. These partnerships are streghthning the market of nuclear imaging in Germany. 

Hence, due to the above-mentioned factors, the market for nuclear imaging is growing rapidly in Germany.

Germany Nuclear Imaging Industry Segmentation

Nuclear medicine imaging procedures are non-invasive, with the exception of intravenous injections, and are usually painless medical tests that help physicians diagnose and evaluate medical conditions. These imaging scans use radioactive materials called radiopharmaceuticals or radiotracers. These radiopharmaceuticals are used in diagnosis and therapeutics. Germany's Nuclear Imaging market is segmented by Product (Equipment, Diagnostic Radioisotopes), and Application (SPECT Applications, PET Applications). The report offers the value (in USD million) for the above segments.

By Product
Equipment
Diagnostic Radioisotope
SPECT Radioisotopes
PET Radioisotopes
By Application
SPECT Applications
Cardiology
Neurology
Thyroid
Other SPECT Applications
PET Applications
Oncology
Cardiology
Neurology
Other PET Applications
Need A Different Region Or Segment?
Customize Now

Germany Nuclear Imaging Market Size Summary

The nuclear imaging market in Germany is poised for significant growth, driven by the increasing prevalence of chronic diseases and the presence of key industry players. Despite the challenges posed by the COVID-19 pandemic, which temporarily disrupted non-essential diagnostic procedures, the market has seen opportunities for innovation and product development. Notable advancements include the study of Lutetium-177, which promises to offer a safer alternative in radiopharmaceuticals. The market's expansion is further supported by strategic partnerships, such as the collaboration between Oncodesign, Covalab, CheMatech, and ABX-CRO, aimed at enhancing theranostic drug development. These collaborations are instrumental in advancing technologies related to target validation, vector optimization, and imaging techniques, thereby strengthening the nuclear imaging sector in Germany.

The demand for nuclear imaging is particularly bolstered by the rising incidence of cancer, which remains a leading cause of morbidity and mortality in the country. With cancer cases on the rise, there is an increasing need for effective early-stage diagnostic methods, and nuclear imaging is recognized as a reliable solution. The effectiveness of PET CT scans in detecting metastasis further underscores the technology's growing importance. The competitive landscape of the market is dominated by major players such as Bracco Imaging SpA, Curium, Cardinal Health Inc., Koninklijke Philips NV, GE Healthcare, and Siemens Healthineers. Recent strategic moves, including acquisitions and exclusive commercial agreements, have further solidified the market's position, with Germany leading in Gallium-68 development in Europe.

Explore More

Germany Nuclear Imaging Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Cancer and Cardiac Disorders

      2. 1.2.2 Technological Advancements in Nuclear Imaging

    3. 1.3 Market Restraints

      1. 1.3.1 Stringent Regulations

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Product

      1. 2.1.1 Equipment

      2. 2.1.2 Diagnostic Radioisotope

        1. 2.1.2.1 SPECT Radioisotopes

        2. 2.1.2.2 PET Radioisotopes

    2. 2.2 By Application

      1. 2.2.1 SPECT Applications

        1. 2.2.1.1 Cardiology

        2. 2.2.1.2 Neurology

        3. 2.2.1.3 Thyroid

        4. 2.2.1.4 Other SPECT Applications

      2. 2.2.2 PET Applications

        1. 2.2.2.1 Oncology

        2. 2.2.2.2 Cardiology

        3. 2.2.2.3 Neurology

        4. 2.2.2.4 Other PET Applications

Germany Nuclear Imaging Market Size FAQs

The Germany Nuclear Imaging Market size is expected to reach USD 504.08 million in 2024 and grow at a CAGR of 4.03% to reach USD 614.17 million by 2029.

In 2024, the Germany Nuclear Imaging Market size is expected to reach USD 504.08 million.

Germany Nuclear Imaging Market Report Snapshots

Germany Nuclear Imaging Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)